Tuesday, 24 March 2026
  
Login

Australia's most trusted
source of pharma news

Tuesday, 24 March 2026
News

$90B time bomb exposed

Posted 24 March 2026 AM

Australia faces a looming $90 billion-a-year obesity crisis without coordinated policy action – including ensuring access to new therapies - a Novo Nordisk commissioned report has found.

Conducted by The McKell Institute and Menzies Research Centre, the report titled A Preventable Crisis, warns that the economic cost of obesity will hit $87.7 billion a year by 2032 and $228 billion annually by 2060, with two-thirds of the costs linked to lost productivity, including absenteeism, reduced workplace performance and premature death.

To see the whole article, please login


Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.